4.5 Article

Delivery of miR-320a-3p by gold nanoparticles combined with photothermal therapy for directly targeting Sp1 in lung cancer

Journal

BIOMATERIALS SCIENCE
Volume 9, Issue 19, Pages 6528-6541

Publisher

ROYAL SOC CHEMISTRY
DOI: 10.1039/d1bm01124c

Keywords

-

Funding

  1. National Natural Science Foundation of China [81772281, 51903015]
  2. Shandong Science and Technology Committee [ZR2019MH022, ZR2020KH015]
  3. Yantai Science and Technology Committee [2018XSCC051]
  4. Scientific Research Foundation of Binzhou Medical University [50012304274, 50012304275]
  5. Shandong Province Taishan Scholar Project [ts201712067]

Ask authors/readers for more resources

A novel nanostructure for delivering miR-320a specifically into lung cancer cells has been developed, showing significant inhibition of proliferation and metastasis, as well as enhanced apoptosis through laser irradiation. Mechanistically, miR-320a inhibits Sp1 expression, enhances PTEN expression, and inhibits MMP9 expression to achieve anticancer effects.
Lung cancer is the second most common tumor and has the highest mortality rate. Both novel therapeutic targets and approaches are needed to improve the overall survival of patients with lung cancer. MicroRNA-320a-3p belongs to the miR-320a family and has been reported as a tumor suppressor in multiple cancers. However, its definitive role and precise mechanism in the progression of lung cancer remain unclear. In this study, we developed a new type of gold nanorod modified with polyethyleneimine that targets cancer-specific nanoparticles by RGD peptide, which could condense miRNA to self-assemble supramolecular nanoparticles. The designed nanoparticles can achieve integrin alpha v beta 3-targeted cancer therapy, realize photosensitive therapy by laser irradiation and attain gene-targeted therapy by miRNAs. These nanoparticles could deliver miR-320a into lung cancer cells specifically and efficiently. Moreover, we demonstrated that Au-RGD-miR-320a nanoparticles combined with laser irradiation dramatically inhibited the proliferation and metastasis, and enhanced the apoptosis of lung cancer, both in vitro and in vivo. In terms of the mechanism, miR-320a inhibits Sp1 expression by directly binding to the 3 ' UTR of Sp1, and it eventually enhanced the expression of PTEN and inhibited the expression of matrix metallopeptidase 9 (MMP9). These findings provide a new and promising anticancer strategy via the use of Au-RGD-miR-320a nanoparticles, and identify miR-320a/Sp1 as a potential target for future systemic therapy against lung cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available